Home/Unlisted Shares/S3V Vascular Technologies Limited

S3V Vascular Technologies Limited

Industry Medical DevicesSector Healthcare

52W HIGH

Rs 680.03

52W LOW

Rs 472.57

1Y RETURN

+22.0%

About the Company

S3V Vascular Technologies manufactures vascular stents, catheter-based devices, and minimally invasive cardiovascular devices for interventional cardiology.

Quick Facts

SectorHealthcare
IndustryMedical Devices
ISINN/A
Face ValueRs 10
52W RangeRs 472.57 to Rs 680.03
Indicative PriceAvailable
Rs 576.3

As of 7 Jul 2026

Quantity

Minimum investment Rs 1,00,000 (174 shares).

Estimated TotalRs 1,00,276
Place Buy Order

Settled in T+1 days. KYC verified dealers.

Get S3V Vascular Technologies Limited's live price

Share a few details and our desk sends you the latest price, availability and how to invest.

Trusted by 5,000+ investors · your details are never shared.

FUNDAMENTALS

Key Indicators

A snapshot of S3V Vascular Technologies Limited's valuation multiples and capital efficiency at a glance.

CURRENT SHARE PRICE

Rs 576.3

FACE VALUE / SHARE

Rs 10

BOOK VALUE / SHARE

Rs 77.97

PRICE TO EARNING (PE)

18833.33

PRICE / BOOK

7.25

MARKET CAP

1.12K Cr

DEBT TO EQUITY

0.13

RETURN ON EQUITY

18%

52 WEEK HIGH

Rs 680.03

52 WEEK LOW

Rs 472.57

FINANCIALS

Fundamentals & Financial Statements

Price / Share

₹565

P/E Ratio

18833.33

P/B Ratio

7.25

Debt to Equity

0.13

Book Value

₹77.97

Face Value

₹10

Lot Size500 shares
Total Shares1,93,87,980
DepositoryNSDL & CDSL
ISININE0HGT01012
CINU33112KA2011PLC059915
PANAAQCS2303F
Registrar (RTA)Aarthi Consultants
Figures in Rs Crore unless stated
Particulars2022202320242025
Revenue21191513.5
Cost of Material Consumed6.68.54.710.3
Change in Inventory1.1-0.60.8-6.9
Gross Margins63.33%58.42%63.33%74.81%
Employee Benefit Expenses22.634.7
Other Expenses5.54.845.97
EBITDA5.83.72.5-0.57
OPM27.62%19.47%16.67%-4.22%
Other Income0.090.080.23.2
Finance Cost1.41.33.51.1
Depreciation & Amortisation1.51.72.071.4
EBIT4.320.43-1.97
EBIT Margins20.48%10.53%2.87%-14.59%
Profit Before Tax2.80.65-3.060.15
PBT Margins13.33%3.42%-20.4%1.11%
Tax0.10.090.130.09
Profit After Tax2.70.56-3.190.06
Net Profit Margin12.86%2.95%-21.27%0.44%
EPS₹2.08₹0.42₹-1.66₹0.03

PROCESS

How to Buy S3V Vascular Technologies Limited

01

Enquire

Share your requirement and preferred quantity with our desk.

02

Get a quote

Receive the latest indicative price, lot size and availability.

03

Complete KYC

Quick paperwork with a KYC-verified counterparty.

04

Receive shares

Shares credited to your demat, typically within T+1 days.

OWNERSHIP

Shareholding Pattern

Promoters & Promoter Group55%
Institutional Investors (FII / DII)18%
Public & HNIs20%
Others / ESOP7%

Indicative ownership structure. Exact filed breakup confirmed at dealing.

BENCHMARK

Peer Comparison

CompanyPriceP/EP/BROEMkt Cap
S3V Vascular Technologies LimitedRs 576.318833.337.2518%1.12K Cr
Martin and Harris LimitedRs 2,21124.001.7616%883.52 Cr
Arch Pharmalabs LimitedRs 93.522.001.8112%1.46K Cr
Anglo-French Drugs & Industries LtdRs 1,609.0125.801.4112%181.82 Cr
East India Pharmaceutical Works LimitedRs 86.923.001.7714%58 Cr

Peers are live Healthcare companies from our catalogue - each figure is that company’s own.

CORPORATE CALENDAR

Events & Announcements

Apr – MayQ4 & full-year (FY) audited results
May – JulDIVIDENDFinal dividend consideration & record date
Jul – SepAnnual General Meeting
Jul – AugQ1 (Jun quarter) results
Oct – NovQ2 & half-year results
Jan – FebQ3 (Dec quarter) results
As announcedBonus / split / rights, if any

Typical annual calendar. Exact dates updated as the company announces them.

LEADERSHIP

Management Team

Standard governance structure. Named directors added as verified. Tap any role to see what they do and why it matters for investors.

REPORTS

Download Financial Results

S3V Vascular Technologies Limited Financial Report

Fundamentals, financial statements and key ratios in one PDF

Need the official filed reports?

Get audited annual & quarterly filings (MCA / RTA) for S3V Vascular Technologies Limited straight from our desk.

QUESTIONS

Frequently Asked Questions

Share your requirement with Neoma Capital, complete a quick KYC, and our desk arranges the transfer from a verified counterparty. Shares are credited to your demat, typically within T+1 working days.

NEWS & INSIGHTS

Latest on S3V Vascular Technologies Limited & its sector

Insights

Cult.Fit IPO & Your Unlisted Shares Investment Strategy

July 2026
Insights

Reimagining Indian Wealth Allocation: Beyond Gold's Gleam

July 2026
Insights

Rentomojo's IPO Nod: The Case for Pre-IPO Investing India

July 2026

CORPORATE

Company Details

#

ISIN

INE0HGT01012

C

CIN

U33112KA2011PLC059915

P

PAN

AAQCS2303F

R

REGISTRAR (RTA)

Aarthi Consultants

D

DEPOSITORY

NSDL & CDSL

S

SECTOR

Healthcare

I

INDUSTRY

Medical Devices

READY TO INVEST?

Enquire with Neoma Capital

Talk to a CA advisor about S3V Vascular Technologies Limited. Get pricing, availability, and transfer process guidance.

Enquire NowWhatsApp Us

Disclaimer: Prices shown are indicative and for reference purposes only. Unlisted shares carry higher risk than listed equities. Past performance is not indicative of future results. Financial statements, where shown, are compiled from company filings (MCA / RTA) and may be restated in subsequent filings. Neoma Capital does not provide investment advice. Please consult a qualified financial advisor. Transactions subject to KYC verification and SEBI regulations.

LinkedInEmail UsChat with us